Shasqi, Inc is a pioneering biotech company based in San Francisco, CA, that is revolutionizing cancer treatment through their innovative Click Activated Protodrugs Against Cancer (CAPAC) approach. Using Nobel Prize-winning click chemistry technology, Shasqi activates cancer therapies specifically at the tumor site, offering a targeted and effective solution for patients.
By separating tumor targeting from the payload and relying on chemistry rather than biology for activation, Shasqi's CAPAC approach provides unprecedented flexibility, potentially leading to enhanced therapeutic activity and reduced toxicity. With their validated clinical success and commitment to advancing novel therapies, Shasqi is at the forefront of transforming cancer treatment and offering hope to patients with limited effective treatment options.
Generated from the website